Poly-L-Lactic Acid and Hyaluronic Acid Fillers Effectively Restore Facial Harmony After GLP-1RA Weight Loss
Background
The increasing use of GLP-1 receptor agonists (GLP-1RAs) for diabetes and obesity management often leads to significant, rapid weight loss. While beneficial for health, this medication-driven weight loss (mdWL) can cause undesirable aesthetic changes such as facial hollowing, skin laxity, and accentuated wrinkles. These changes can impact patient satisfaction and self-perception. There is a clear need for effective, minimally invasive aesthetic strategies specifically tailored to restore facial harmony in individuals undergoing GLP-1RA-induced mdWL.
Study Design
This retrospective, multicenter, real-world case series included 15 women (aged 30-50 years) from four Latin American countries. All participants were using GLP-1RAs for medication-driven weight loss. They received combined injections of poly-L-lactic acid (PLLA-SCA) and hyaluronic acid fillers for facial rejuvenation. Outcomes were assessed at baseline and around 85-100 days (D90) using the Facial Laxity Rating Scale (FLRS), Wrinkle Severity Rating Scale (WSRS), Global Aesthetic Improvement Scale (GAIS; participant and investigator assessments), and a satisfaction questionnaire. Safety events were also recorded.
Results
Participants achieved a substantial 17.9% weight reduction from baseline due to their GLP-1RA therapy. At D90, FLRS scores significantly decreased from 4.5 (SD 2.2) to 2.6 (SD 1.8; p<0.001), demonstrating a marked reduction in facial laxity. Similarly, WSRS scores improved from 3.1 (SD 1.5) to 1.9 (SD 1.0; p=0.003), indicating smoother wrinkles.
Eight patients (53%) reduced FLRS by ≥2 points, and 11 of 13 patients (85%) with baseline WSRS >1 showed improvement. All participants reported aesthetic improvement on the patient
GAIS(pGAIS), with 40% rating their improvement as "exceptional". InvestigatorGAISconfirmed improvement in 100% of cases. At D90, 87% of participants were satisfied or very satisfied with the aesthetic outcomes. No serious adverse events occurred; transient ecchymoses and edema resolved spontaneously within 72 hours.
Key Findings
- Participants achieved 17.9% weight reduction from GLP-1RA therapy.
- Facial Laxity Rating Scale (FLRS) scores decreased from 4.5 to 2.6 (p<0.001).
- Wrinkle Severity Rating Scale (WSRS) scores decreased from 3.1 to 1.9 (p=0.003).
- 53% of patients reduced FLRS by ≥2 points, and 85% with baseline WSRS >1 showed improvement.
- 100% of cases showed aesthetic improvement by investigator assessment, with 87% patient satisfaction.
Why It Matters
This study provides compelling real-world evidence for a combined injectable strategy to effectively counteract the aesthetic side effects of GLP-1RA-induced weight loss. For individuals experiencing facial volume loss, hollowing, or laxity from rapid weight reduction, this protocol offers a practical and highly satisfactory solution to restore a more youthful and harmonious facial appearance. The high patient satisfaction and favorable safety profile suggest this approach could become a standard adjunctive treatment in aesthetic practices for GLP-1RA users. While specific filler volumes were not detailed, the validated strategy of combining PLLA-SCA for collagen stimulation and hyaluronic acid for immediate volume provides a clear framework for clinicians and biohackers addressing these specific cosmetic concerns.
poly-l-lactic acid
hyaluronic acid
glp-1ra
weight loss
facial aesthetics
skin laxity